Eikon Therapeutics

EIKNNasdaq United States Health Care Biotechnology: Biological Products (No Diagnostic Substances)

Market cap

$315.782 M

$5.83 -8.76%

Close of 6 Nov 2026

As of 6 Nov 2026, Eikon Therapeutics (EIKN) has a market capitalization of $315.8M. Market cap measures the value of outstanding equity at market prices; company totals combine applicable share classes. Prices and market caps come from Nasdaq, with financial fundamentals from SEC filings. See sources and calculation details.

Revenue

—

Not reported

Earnings

—

Not reported

Shares outstanding

54,165,030

Latest filing cover page

P/E ratio

—

Cap ÷ net income

Biotechnology: Biological Products (No Diagnostic Substances), ranked by market cap

All 163 →

#78Fennec PharmaceuticalsFENC$327.6M
#79ProkidneyPROK$322.0M
#80Eikon TherapeuticsEIKN$315.8M
#81X4 PharmaceuticalsXFOR$314.0M
#82AlectorALEC$310.6M

What if Eikon Therapeutics were worth as much as…

Open the what-if tool →

Gold $28.2T

$521,311.88

Per share 89,419× higher

Bitcoin $1.53T

$28,207.28

Per share 4,838× higher

Apple $5.02T

$92,601.86

Per share 15,884× higher

Or at a round number

$500.0M $1.00B $2.00B $5.00B

Where these numbers come from

Share counts and financials for Eikon Therapeutics are taken from its own SEC filings via EDGAR: public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Read the methodology.